The Almac Group on Wednesday, May 18 celebrated the official grand opening of its new North American Headquarters in Souderton, PA.
The $120 million, 240,000-square-foot new North American headquarters houses more than 800 employees and has already brought approximately 300 new hires to the greater Philadelphia region. With global headquarters in Craigavon, Northern Ireland, Almac employs more than 3,000 worldwide, with over 1,100 employees based in the US.
Officially opening the building was former US Senator George J. Mitchell, who was Chairman of the historic 1998 Northern Ireland Peace Agreement. Until last week, Mitchell served as President Obama’s Special Envoy to the Middle East. Commenting on the new facility, Mitchell said, “Almac’s Founder Sir Allen McClay had a real vision for this company, and the building we are dedicating today will be a fitting monument to his life and work. This facility will be important not only to the economy of Pennsylvania, but to the health of people all over the world."
In addition to Senator Mitchell, several other dignitaries participated in the grand opening. These include Pennsylvania Department of Community and Economic Development Secretary C. Alan Walker, who attended on behalf of Pennsylvania Governor Tom Corbett, and Almac CEO Alan Armstron.
Lady Heather McClay, wife of the late Sir Allen McClay , dedicated three unique pieces of stained glass commissioned especially for the headquarters. The glass works are interwoven with scientific references, symbols associated with Northern Ireland, as well as images from the official crest of Pennsylvania.
Almac’s new North American headquarters, comprised of a three-story office and administration building, as well as a building for the production, analysis and distribution of clinical trial supplies, was designed by Francis Cauffman Architects of Philadelphia and built by Skanska USA. It strives to maintain sustainability throughout, with low greenhouse gas emissions and a full water reclamation program in place.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.